Cognios Beta Neutral Large Cap Fund’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$524K Sell
2,433
-241
-9% -$50.6K 0.68% 53
2023
Q4
$563K Sell
2,674
-315
-11% -$67.2K 0.73% 50
2023
Q3
$598K Sell
2,989
-798
-21% -$159K 0.78% 47
2023
Q2
$702K Sell
3,787
-1,427
-27% -$264K 0.81% 53
2023
Q1
$986K Sell
5,214
-85
-2% -$15.4K 0.94% 39
2022
Q4
$891K Buy
+5,299
New +$921K 0.86% 57
2018
Q2
$2.01M Buy
+12,273
New +$2M 0.7% 81

Other funds holding CME

Cognios Beta Neutral Large Cap Fund's CME Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its CME Group (CME) stake by 9% in Q1 2024, selling an estimated $50.6K and leaving 2,433 shares worth $524K. The position accounts for 0.68% of the portfolio, ranked #53.

Cognios Beta Neutral Large Cap Fund first reported a position in CME in Q2 2018 and has held it in 7 quarters since. The position peaked at $2.01M in Q2 2018. 1,373 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund held 2,433 shares of CME Group worth $524K as of Q1 2024.
  • Cognios Beta Neutral Large Cap Fund sold 241 CME Group shares in Q1 2024, an estimated $50.6K.
  • CME Group made up 0.68% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #53 holding.
  • Cognios Beta Neutral Large Cap Fund first reported a position in CME Group in Q2 2018 and has held it in 7 quarters since.
  • Cognios Beta Neutral Large Cap Fund's CME Group position peaked at $2.01M in Q2 2018.
  • 1,373 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.